Literature DB >> 24953647

Hypertension and obesity: correlates with renin-angiotensin-aldosterone system and uric acid.

Gema Ruiz-Hurtado1, Luis M Ruilope.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24953647      PMCID： PMC8032183          DOI： 10.1111/jch.12356

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  16 in total

1.  Effect of allopurinol in chronic kidney disease progression and cardiovascular risk.

Authors:  Marian Goicoechea; Soledad García de Vinuesa; Ursula Verdalles; Caridad Ruiz-Caro; Jara Ampuero; Abraham Rincón; David Arroyo; José Luño
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-10       Impact factor: 8.237

2.  Resurrection of uric acid as a causal risk factor in essential hypertension.

Authors:  Richard J Johnson; Dan I Feig; Jaime Herrera-Acosta; Duk-Hee Kang
Journal:  Hypertension       Date:  2004-11-22       Impact factor: 10.190

Review 3.  Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status.

Authors:  Terry K W Ma; Kevin K H Kam; Bryan P Yan; Yat-Yin Lam
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

Review 4.  Serum uric acid and cardio-renal diseases.

Authors:  L M Ruilope; R Pontremoli
Journal:  Curr Med Res Opin       Date:  2013-04       Impact factor: 2.580

5.  Uric acid reduction rectifies prehypertension in obese adolescents.

Authors:  Beth Soletsky; Daniel I Feig
Journal:  Hypertension       Date:  2012-09-24       Impact factor: 10.190

6.  Serum aldosterone and the incidence of hypertension in nonhypertensive persons.

Authors:  Ramachandran S Vasan; Jane C Evans; Martin G Larson; Peter W F Wilson; James B Meigs; Nader Rifai; Emelia J Benjamin; Daniel Levy
Journal:  N Engl J Med       Date:  2004-07-01       Impact factor: 91.245

7.  The impact of serum uric acid on cardiovascular outcomes in the LIFE study.

Authors:  Aud Høieggen; Michael H Alderman; Sverre E Kjeldsen; Stevo Julius; Richard B Devereux; Ulf De Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Cong Chen; Björn Dahlöf
Journal:  Kidney Int       Date:  2004-03       Impact factor: 10.612

Review 8.  Uric acid and cardiovascular risk.

Authors:  Daniel I Feig; Duk-Hee Kang; Richard J Johnson
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245

9.  European Society of Hypertension Working Group on Obesity Obesity-induced hypertension and target organ damage: current knowledge and future directions.

Authors:  Markus P Schlaich; Guido Grassi; Gavin W Lambert; Nora Straznicky; Murray D Esler; John Dixon; Elisabeth A Lambert; Josep Redon; Krzysztof Narkiewicz; Jens Jordan
Journal:  J Hypertens       Date:  2009-02       Impact factor: 4.844

10.  Blood pressure and uric acid in diabetes mellitus.

Authors:  Luis M Ruilope
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-03-26       Impact factor: 3.738
View more
  6 in total

1.  Hyperuricemia and high blood pressure at rest and during exercise: Guilty or innocent? The jury is still out.

Authors:  Giuseppe Mulè; Emilio Nardi; Luigi Lattuca; Santina Cottone
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-02-19       Impact factor: 3.738

2.  Serum uric acid level as a cardio-cerebrovascular event risk factor in middle-aged and non-obese Chinese men.

Authors:  Zhi-Jun Li; Chen-Ju Yi; Jing Li; Na Tang
Journal:  Oncotarget       Date:  2017-04-11

3.  Regulation of alternative splicing in obesity-induced hypertension.

Authors:  Zodwa Dlamini; Rodney Hull; Tshepiso J Makhafola; Mzwandile Mbele
Journal:  Diabetes Metab Syndr Obes       Date:  2019-08-28       Impact factor: 3.168

4.  Obesity-related hypertension: Findings from The Korea National Health and Nutrition Examination Survey 2008-2010.

Authors:  Hong Seok Lee; Yong-Moon Park; Kyungdo Han; Jin-Hong Yang; Seungwon Lee; Seong-Su Lee; Soonjib Yoo; Sung Rae Kim
Journal:  PLoS One       Date:  2020-04-21       Impact factor: 3.240

5.  Genetic Deletion of NOD1 Prevents Cardiac Ca2+ Mishandling Induced by Experimental Chronic Kidney Disease.

Authors:  Marta Gil-Fernández; José Alberto Navarro-García; Almudena Val-Blasco; Laura González-Lafuente; José Carlos Martínez; Angélica Rueda; Maria Tamayo; José Luis Morgado; Carlos Zaragoza; Luis Miguel Ruilope; Carmen Delgado; Gema Ruiz-Hurtado; María Fernández-Velasco
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

6.  Association Between Uric Acid and Renal Hemodynamics: Pathophysiological Implications for Renal Damage in Hypertensive Patients.

Authors:  Giulio Geraci; Giuseppe Mulè; Manuela Mogavero; Calogero Geraci; Emilio Nardi; Santina Cottone
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-03-25       Impact factor: 3.738
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.